Researchers find Easier Way to Make Stem Cells
By Thomson Financial News,
Thomson Financial News
| 10. 12. 2008
WASHINGTON, Oct 12 (Reuters) - Researchers trying to find ways to transform ordinary skin cells into powerful stem cells said on Sunday they found a shortcut by 'sprinkling' a chemical onto the cells.
Adding the chemical allowed the team at the Harvard Stem Cell Institute in Massachusetts to use just two genes to transform ordinary human skin cells into more powerful induced pluripotent stem cells or iPS cells.
'This study demonstrates there's a possibility that instead of using genes and viruses to reprogram cells, one can use chemicals,' said Dr. Doug Melton, who directed the study published in the journal Nature Biotechnology.
Melton said Danwei Huangfu, a postdoctoral researcher in his lab, developed the new method.
'The exciting thing about Danwei's work is you can see for the first time that you could sprinkle chemicals on cells and make stem cells,' Melton, a Howard Hughes Medical Institute Investigator, said in a statement.
Stem cells are the body's master cells, giving rise to all the tissues, organs and blood. Embryonic stem cells are considered the most powerful kinds of stem cells...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...